Insider · CIK 0002000747
Bios Equity COF, LP
Files at ACTU (ACTUATE THERAPEUTICS, INC.), INAB (IN8BIO, INC.). First filing Jun 30, 2025, latest Jun 30, 2025.
In brief
Bios Equity COF, LP files SEC Form 4 as 10% owner and director at ACTU (ACTUATE THERAPEUTICS, INC.), and also at INAB (IN8BIO, INC.). Since Jun 30, 2025, Bios Equity COF, LP has reported 1 open-market buy worth $500k and 0 open-market sells worth $0, the latest filed on Jun 30, 2025.
A track record needs three past buys with six months of prices behind them; Bios Equity COF, LP has 0, so none is measured yet.
The newest scored trade: bought $500k of ACTU on Jun 27, 2025, filed Jun 30, 2025, scored 58 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ACTU: ACTUATE THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | ACTUATE THERAPEUTICS, INC. | $500k 71,428 shares | +57% | - |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 27, 2025 | ACTU ACTUATE THERAPEUTICS, INC. | POpen-market purchase Common Stockindirect: Directly held by Bios 2024 Co-Invest, LP | +71,428 | $7.00 | $500k | 196,428 | Jun 30, 2025 |
| Jun 27, 2025 | ACTU ACTUATE THERAPEUTICS, INC. | POpen-market purchase Warrant (Right to Buy)derivativeindirect: Directly held by Bios 2024 Co-Invest, LP | +71,428 | $0.00 | $0 | 71,428 | Jun 30, 2025 |
Questions about Bios Equity COF, LP
Answered from the filings on this page, as of the latest one.
Is Bios Equity COF, LP buying or selling?
Not in the last 12 months. Bios Equity COF, LP's latest open-market trade on SEC Form 4 was bought $500k of ACTU on Jun 27, 2025.
How did Bios Equity COF, LP's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bios Equity COF, LP has 0.
Where does Bios Equity COF, LP file Form 4?
Bios Equity COF, LP has filed Form 4 at ACTU (ACTUATE THERAPEUTICS, INC.); INAB (IN8BIO, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.